Insider Transactions in Q3 2022 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2022
|
Giovanni Caforio Executive Chair of the Board |
SELL
Open market or private sale
|
Direct |
25,000
-4.99%
|
$1,725,000
$69.71 P/Share
|
|
Sep 15
2022
|
Giovanni Caforio Executive Chair of the Board |
SELL
Open market or private sale
|
Direct |
50,000
-9.07%
|
$3,550,000
$71.84 P/Share
|
|
Sep 14
2022
|
Ann Powell EVP, Chief Human Resources |
SELL
Open market or private sale
|
Direct |
25,000
-33.12%
|
$1,750,000
$70.75 P/Share
|
|
Sep 13
2022
|
David V Elkins EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
133,951
-34.73%
|
$9,510,521
$71.32 P/Share
|
|
Sep 13
2022
|
David V Elkins EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
123,277
+18.56%
|
$5,917,296
$48.49 P/Share
|
|
Jul 01
2022
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,786
-18.35%
|
$363,736
$76.84 P/Share
|
|
Jul 01
2022
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
BUY
Exercise of conversion of derivative security
|
Direct |
9,356
+26.4%
|
-
|
|
Jul 01
2022
|
Michelle Weese EVP, Corporate Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
682
-36.18%
|
$51,832
$76.84 P/Share
|
|
Jul 01
2022
|
Michelle Weese EVP, Corporate Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
1,885
+50.0%
|
-
|